SCYNEXIS shareholders reject officer liability limit; approve equity plans

Proposal 3: Advisory approval of the compensation of SCYNEXIS's named executive officers as disclosed in this Proxy Statement, was approved. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 13,038,648 3,868,468 334,699 9,302,100

Proposal 4: The amendment of the SCYNEXIS, Inc. Amended and Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of SCYNEXIS as permitted pursuant to recent amendments to the Delaware General Corporation Law, as described in the Proxy Statement, was not approved, as this proposal required a vote of the majority of the shares outstanding (rather than simply a majority of the shares present and entitled to vote), which vote was not obtained (a total of 36,517,442 shares were outstanding on the record date). The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 12,978,798 4,069,555 193,462 9,302,100

Proposal 1: Each of the seven directors proposed by SCYNEXIS for re-election was elected to serve until SCYNEXIS’s 2024 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified. The tabulation of votes on this matter was as follows: For Withheld Broker Non-Votes David Angulo, M.D. 16,502,205 739,610 9,302,100 Armando Anido 16,015,447 1,226,368 9,302,100 Steven C. Gilman, Ph.D. 16,141,648 1,100,167 9,302,100 Ann F. Hanham, Ph.D. 16,267,526 974,289 9,302,100 David Hastings 14,175,218 3,066,597 9,302,100 Guy Macdonald 16,474,638 767,177 9,302,100 Philippe Tinmouth 16,493,678 748,137 9,302,100

Proposal 2: The appointment of Deloitte & Touche LLP as SCYNEXIS’s independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 25,161,193 1,133,817 248,905 —

Proposal 6: The SCYNEXIS, Inc. Amended and Restated 2014 Employee Stock Purchase Plan was approved. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 15,588,230 1,474,343 179,242 9,302,100

Proposal 5: The SCYNEXIS, Inc. 2023 Equity Incentive Plan was approved. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 9,751,905 7,212,033 277,877 9,302,100